Holen Sie sich die Stockscreener-App
294.73
2.40%
6.92
Handel nachbörslich:
294.48
-0.25
-0.08%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CI?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$287.81
Offen:
$286.95
24-Stunden-Volumen:
2.42M
Relative Volume:
1.34
Marktkapitalisierung:
$77.65B
Einnahmen:
$216.66B
Nettoeinkommen (Verlust:
$6.25B
KGV:
13.28
EPS:
22.1869
Netto-Cashflow:
$7.44B
1W Leistung:
+8.47%
1M Leistung:
+5.66%
6M Leistung:
+6.39%
1J Leistung:
-0.17%
1-Tages-Spanne:
$283.19
$296.36
1-Wochen-Bereich:
$273.95
$297.80
52-Wochen-Spanne:
$239.51
$350.00
Cigna Group Stock (CI) Company Profile
Firmenname
Cigna Group
Sektor
Branche
Telefon
(860) 226-6000
Adresse
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
294.73 | 75.83B | 216.66B | 6.25B | 7.44B | 22.19 |
|
UNH
Unitedhealth Group Inc
|
278.91 | 247.49B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
77.02 | 96.10B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
330.25 | 71.87B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
175.40 | 21.81B | 126.36B | 1.30B | 1.55B | 10.67 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-02-06 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-02-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-06-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-22 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-27 | Fortgesetzt | Bernstein | Mkt Perform |
| 2022-05-26 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-02-07 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-17 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-06 | Bestätigt | BofA Securities | Buy |
| 2021-08-06 | Bestätigt | Citigroup | Buy |
| 2021-08-06 | Bestätigt | Deutsche Bank | Buy |
| 2021-08-06 | Bestätigt | Jefferies | Buy |
| 2021-08-06 | Bestätigt | Mizuho | Buy |
| 2021-08-06 | Bestätigt | Oppenheimer | Outperform |
| 2021-08-06 | Bestätigt | Truist | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-08-06 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Eingeleitet | UBS | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-24 | Eingeleitet | Edward Jones | Buy |
| 2018-03-13 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-12 | Eingeleitet | Credit Suisse | Outperform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Cigna Group Aktie (CI) Neueste Nachrichten
Mark Cuban Urges Trump To 'Put His Weight Behind' Josh Hawley, Elizabeth Warren's 'Break Up Big Medicine Act' - Benzinga
This Week's Healthcare Earnings: Lilly, Cigna And More - Law360
How Investors Are Reacting To Cigna Group (CI) Earnings Beat, Massive Buybacks And Dividend Hike - Yahoo Finance
Cigna to lay off 2,000 workers worldwide - Healthcare Dive
Cigna to Remedy Years of Unfair Business Practices with Patients and Pharmacies - Drug Topics
Cigna to cut 2,000 jobs - Healthcare Finance News
Deutsche Bank Aktiengesellschaft Forecasts Strong Price Appreciation for Cigna Group (NYSE:CI) Stock - MarketBeat
Deutsche Bank Raises Price Target on Cigna Group to $304 From $301, Keeps Buy Rating - marketscreener.com
Cigna Group $CI Shares Acquired by Oppenheimer Asset Management Inc. - MarketBeat
Providence Capital Advisors LLC Acquires 7,748 Shares of Cigna Group $CI - MarketBeat
Cigna to cut 2,000 positions this month - Modern Healthcare News
Cigna Healthcare Returns as Title Sponsor of the Denver Colfax Marathon - Endurance Sportswire
The Cigna Group Named Top Dividend Stock With Insider Buying and 2.14% Yield (CI) - Nasdaq
CI: TD Cowen Raises Price Target for Cigna Group to $338 | CI St - GuruFocus
Landmark Settlement: The Cigna Group Resolves FTC Insulin Pricing Suit, Reshaping the PBM Landscape - FinancialContent
Cigna Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Present Moments Recovery Now In-Network with Cigna & Evernorth Be - The National Law Review
TD Cowen Maintains Cigna Group(CI.US) With Buy Rating, Raises Target Price to $338 - 富途牛牛
Jefferies Adjusts Price Target on Cigna to $333 From $310, Maintains Buy Rating - marketscreener.com
TD Cowen Adjusts Price Target on Cigna to $338 From $333, Maintains Buy Rating - marketscreener.com
The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend - Eastern Progress
A Look At Cigna Group (CI) Valuation After Earnings Beat Dividend Hike And FTC Settlement - simplywall.st
There's Been No Shortage Of Growth Recently For Cigna Group's (NYSE:CI) Returns On Capital - Yahoo Finance
Cigna FTC Settlement Reshapes Express Scripts Model And Investor Outlook - simplywall.st
Bloomfield-based health-care giant Cigna Group and FTC settle insulin-price lawsuit - CT Insider
Cigna Executives See Little ’26 Movement in Enrollment, Cost Ratio - HCI Innovation Group
Cigna Group (CI) Analyst Rating Update: RBC Capital Maintains wi - GuruFocus
FTC Deal Reshapes Cigna’s Express Scripts Margins And PBM Positioning - simplywall.st
News | Insurance giant Cigna sheds half of its downtown Philadelphia hub - CoStar
Is The Cigna Group Gaining or Losing Market Support? - Benzinga
Cigna Shows Greater Stability Amid Policy Uncertainty, RBC Says - marketscreener.com
Cigna Group (CI) Buy Rating Maintained by Guggenheim with Increa - GuruFocus
Cigna Group (CI) Analyst Rating: Barclays Lowers Price Target | - GuruFocus
BofA Securities Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $378 - 富途牛牛
RBC Trims Price Target on Cigna Group to $333 From $344, Keeps Outperform Rating - marketscreener.com
Cigna Corporation (NYSE:CI) Q4 2025 Earnings Call Transcript - Insider Monkey
CI Q4 Deep Dive: PBM Model Transition and Specialty Growth Drive Positive Results - Finviz
Cigna Group Q4 Earnings Call Highlights - Yahoo Finance
Cigna posts US$6 billion profit on double‑digit 2025 revenue growth - Insurance Business
Cigna posts $6 billion profit on double‑digit 2025 revenue growth - Insurance Business
FTC, Cigna settle PBM insulin lawsuit - Modern Healthcare News
Cigna’s Reassurances About PBM Business Lift Stock - The Wall Street Journal
Cigna beats quarterly estimates, provides muted outlook | Business Information & News | FE - Westlaw Today
Cigna Earnings Call: Growth Holds Amid PBM Overhaul - TipRanks
The Cigna Group (CI) Q4 2025 Earnings Call Highlights: Strong Re - GuruFocus
The Cigna Group (CI) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Website Wiretapping Claims Trimmed From Cigna Suit - Law360
CignaContinued Downside In 2026E (NYSE:CI) - Seeking Alpha
The Cigna Group (CI) Stock Price Up 2.81% on Feb 5 - GuruFocus
Cigna hails pharmacy deal with the FTC, battles elevated cost trends - InsuranceNewsNet
Cummins Revenue Holds Up as Charges Weigh on Near-Term Earnings Clarity - Investing.com
Finanzdaten der Cigna Group-Aktie (CI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.42%
3.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):